DealShot

DealShot: Qiming Venture Partners Leads $17M Series A Round In Chinese Biotech Firm CureGenetics

Follow Us:
LinkedIn
Twitter
YouTube
Facebook
Weibo

China Money Network’s DealShot provides detailed information on venture capital and private equity deals in China on a daily basis.

Here you can find out where Chinese investors have been investing their money each workday.

CompanyRoundLead InvestorParticipantsSectorHeadquarters
CureGeneticsSeries AQiming Venture PartnersQingsong Capital, Shengding InvestmentHealthcareSuzhou
WoLongSequoia Capital ChinaE-commerceQingdao
Shunzhi TechnologyAngel RoundYuexiu Industrial FundMefund CapitalHealthcareShanghai
GenedockSeries BMorningside Venture CapitalBaidu Ventures, BGI Genomics, Shanghai Furong Investment Co., LtdHealthcareBeijing
Santi TechnologyAngel RoundMontnetsEnterprise servicesHangzhou
ChargerlinkPre-BCDH InvestmentsTransportation & SpaceShenzhen
UesmartAngel RoundAnroad CapitalEnterprise servicesShenzhen
Tianrang IntelligenceSeries ACMB International, Gaorong CapitalPurple Cow Startups, WacaiEnterprise servicesShanghai
Lihan ScienceSeries AShanghai Zhongyizhijiao Equity Investment Fund Management Co., LtdEducationWuhan
News.oneAngel RoundNode CapitalBlockchainBeijing
YidebangSeries A+Fosun PharmaHealthcareBeijing
Tianxiang Aviation TechnologySeries ATopsailingYonghua CapitalAI & RoboticsGuangzhou
Eagle DriveSeries AEverest Capital(LMFVC)KingCapitalAI & RoboticsShenzhen
FeigeshangpinSeries AChina Growth Capital, Buhuo VenturesE-commerceBeijing
UUPaotuiSeries BFortune Link Venture CapitalLogisticsZhengzhou
Yee CoffeeSeries AYonghua CapitalConsumer UpgradeBeijing
 


Related News








Leave a Reply

Your email address will not be published. Required fields are marked *